You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》康基醫療集資最多31.3億元 引資七基石投資者共1.65億美元
阿思達克 06-15 11:24
據本網取得的銷售文件,內地醫療器械公司康基醫療將發行2.25億股,其中10%於本港作公開發售,招股價介乎12.36元至13.88元,集資額介乎3.25億美元至4.04億美元,換算港幣介乎25.19億元至31.31億元。

文件並披露,康基醫療基石投資者共認購1.65億美元股份,其中富達投資附屬Fidelity Management & Research(FMR)認購4,500萬美元,貝萊德認購3,500萬美元、清池資本認購2,500萬美元,另外高瓴資本、Cormorant Asset Management、私募基金OrbiMed及橡樹資本各認購1,500萬美元。

早前其上市申請披露,聯席保薦人為高盛、中信里昂證券及美銀證券。另有外電報道,公司計劃於本月29日上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account